Africa’s first Ebola vaccine trial starts in Mali

2014-10-10 10:50

Three people in Mali were injected with an experimental Ebola vaccine, the first such trial on African soil, says the health ministry.

The volunteers were among 40 Malian health workers who agreed to participate in an international trial of the cAd3-EBO-Z vaccine, which was developed by the National Institute of Allergy and Infectious Diseases in Maryland in the United States.

The trial vaccine was previously tested on chimpanzees and was found to stimulate an immune response in the apes against the Ebola virus.

“We should be able to have very preliminary safety results and even some immunology results by the end of November,” said Samba Sow, director-general of the Center for Vaccine Development in the capital, Bamako.

It is expected to take several months before small amounts of the vaccine will be available, Sow said.

One volunteer, a 37-year-old paediatrician, said he decided to participate in the trial to help save lives. He was hoping to become immune to the Ebola virus, the unnamed doctor said, “because if we have a case of Ebola in Mali, I would want to be called to be involved in treating that person”.

Southwest Mali borders Guinea, one of the worst-affected countries along with Sierra Leone and Liberia.

Initial trials of the vaccine started in September on healthy individuals in the United States and Britain and 40 people are also to take part in Gambia.

A trial for a second vaccine developed by Canada’s health agency is being conducted in the US.

More than 8 000 Ebola cases have been reported in West Africa and almost half the patients have died, according to the World Health Organisation.

Join the conversation! encourages commentary submitted via MyNews24. Contributions of 200 words or more will be considered for publication.

We reserve editorial discretion to decide what will be published.
Read our comments policy for guidelines on contributions. publishes all comments posted on articles provided that they adhere to our Comments Policy. Should you wish to report a comment for editorial review, please do so by clicking the 'Report Comment' button to the right of each comment.

Comment on this story
Comments have been closed for this article.

Inside News24

Traffic Alerts
There are new stories on the homepage. Click here to see them.


Create Profile

Creating your profile will enable you to submit photos and stories to get published on News24.

Please provide a username for your profile page:

This username must be unique, cannot be edited and will be used in the URL to your profile page across the entire network.


Location Settings

News24 allows you to edit the display of certain components based on a location. If you wish to personalise the page based on your preferences, please select a location for each component and click "Submit" in order for the changes to take affect.

Facebook Sign-In

Hi News addict,

Join the News24 Community to be involved in breaking the news.

Log in with Facebook to comment and personalise news, weather and listings.